This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
The Institute of Cancer Research in London recently announced the launch of a center that will bring together drug developers and evolutionary biologists to tackle drug resistance. Research at the center will focus on designing better combination strategies for existing cancer therapies based on how tumors evolve, and developing new drugs that target the evolution of cancer.
- ©2019 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
Published OnlineFirst July 24, 2019
doi: 10.1158/2159-8290.CD-NB2019-087
New Center Takes Aim at Resistance
Jump to section
Advertisement